Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
HeartScore® is the electronic counterpart of the SCORE risk charts. Designed for health professionals, HeartScore® combines rapid total risk prediction with management advice. The online tool that can significantly improve the quality of the prevention programmes in everyday clinical practice.
Access HeartScore Now! Access HeartScore web-based version, available in 14 national versions and 17 languages or download the PC version
HeartScore® can be easily adapted to different countries to offer clinicians a rapid, interactive access to appropriate local preventive advice. Several Country-Specific and translated versions of HeartScore® have been developed in close collaboration with the National Coordinator for CVD Prevention and the National Cardiac Societies.
Being flexible and interactive, HeartScore® can be updated in real-time as new cohort studies become available, and can incorporate new languages, new risk factors and new endpoints.